---
category: news
title: "Adaptive Biotechnologies: Becoming The Next Big Thing In The Biotech Industry"
excerpt: "Adaptive Biotech product 'clonoSEQ' is the first MRD test cleared by FDA for multiple myeloma, CLL, and B-ALL. See why investors should consider adding ADPT stock to their portfolio."
publishedDateTime: 2022-04-15T11:58:00Z
originalUrl: "https://seekingalpha.com/article/4501632-adaptive-biotechnologies-becoming-next-big-thing-in-biotech-industry"
webUrl: "https://seekingalpha.com/article/4501632-adaptive-biotechnologies-becoming-next-big-thing-in-biotech-industry"
type: article
quality: 1
heat: 1
published: false

provider:
  name: Seeking Alpha
  domain: seekingalpha.com

topics:
  - AI in Healthcare
  - AI

secured: "nSYtVDnukO6mlQNPcHbqPT6soW50pBSvphaCr4+e/aDQdPCR1nz9WWxfuMpGPMlaW0WwAaU4ZDZD7UWR5VpPkPYKaU2HdisGCktm44pyZG1QWQvPgjqOpKLafR/OJV6w17ojn6WQX9HfU+Aa3xnEW6q7EkwGLwzQgTUEWb9OyjIb+ylRPsY6+Jy8LqunLC+PPVSegHE0/27LTOV8ziKhHJNHYSiAysO8YIMQau9nhCcKKLwQ/pi7k0U9NgFep0VbfCnx52x9CoNRh3RgOZgn991hBnpor/k9wps/zwx099xYoB1Jqqpm6Hfi14n+jKhFoAkyVrsuvS6VMIlSC27fsl/DkP0HxnGEET0AgTC9FAsGUEmF6cyPA2f5asT2B/s33Ead4crtmbJK//jCMlL99/ZNbzzcbni7RUyTfgNASHlWzVPqUV70nnCiag9aJBioAsY3F+jljRbGyI6u8YcWrWb+LFMJLeeWn+cGMBCS5aRyBMbWIwfo00BM9zLPMK40qavjEEoALLOR58ed8If3Xg==;GMUbPhEGKUZ9uDho7CsSRw=="
---

